Summary
Medtronic plc (MDT) has filed an 8-K report detailing a significant debt offering that closed on September 29, 2020. The company's subsidiary, Medtronic Global Holdings S.C.A. ("Medtronic Luxco"), successfully issued approximately €6.2 billion in aggregate principal amount of senior notes across various maturities, ranging from 2023 to 2050. Notably, several tranches of these new notes carry a 0.000% interest rate, reflecting favorable borrowing conditions for the company at the time. The proceeds from this offering are earmarked for the repayment of existing debt, including maturing Floating Rate Senior Notes and the redemption of several other series of outstanding notes from Medtronic Luxco, Medtronic, Inc., and Covidien International Finance S.A. This debt issuance is a strategic move by Medtronic to refinance its debt profile, potentially lowering its overall interest expense and extending its debt maturity. The repayment of specific outstanding notes, including those with higher interest rates, suggests a proactive approach to managing its capital structure. The company has also applied to list these new notes on the New York Stock Exchange, which should enhance their liquidity and accessibility for investors.
Key Highlights
- 1Medtronic Luxco issued approximately €6.2 billion in senior notes across multiple maturities (2023-2050) through an underwritten offering.
- 2Several tranches of the new notes, including those due in 2023 and 2025, bear a 0.000% interest rate.
- 3Proceeds will be used to repay maturing Medtronic Luxco Floating Rate Senior Notes due March 7, 2021.
- 4The offering will also fund the redemption of various outstanding notes from Medtronic Luxco, Medtronic, Inc., and CIFSA, including significant principal amounts of 3.150%, 2.750%, and 3.625% notes.
- 5The new notes are fully and unconditionally guaranteed by Medtronic plc and Medtronic, Inc.
- 6Medtronic has applied to list these new notes on the New York Stock Exchange.
- 7The debt is structured with various call options for early redemption by Medtronic Luxco.